Has anyone had a look at the Revenue for the 31 December 2017 period of $519,638 which declined by 40% by it's previous year's interim Revenue for the period of 31 December 2016 of $883,782?
What going on here? It seems that they have uped the Marketing spend, I personally have no issue there.
But why have the sales declined by 40%?
- Forums
- ASX - By Stock
- SWF
- Ann: Appendix 4D & Half Year Financial Statements
Ann: Appendix 4D & Half Year Financial Statements, page-2
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SWF (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.8¢ |
Change
0.088(72.9%) |
Mkt cap ! $48.45M |
Open | High | Low | Value | Volume |
21.0¢ | 21.3¢ | 20.8¢ | $1.599M | 7.634M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 2114823 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 1143588 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 2114823 | 0.205 |
10 | 2563883 | 0.200 |
6 | 389564 | 0.195 |
2 | 143578 | 0.190 |
2 | 115000 | 0.185 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 1143588 | 23 |
0.215 | 1250536 | 10 |
0.220 | 434959 | 12 |
0.225 | 232222 | 3 |
0.240 | 92000 | 2 |
Last trade - 13.24pm 13/11/2024 (20 minute delay) ? |
Featured News
SWF (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online